COVID-19 in children and young adults with kidney disease: risk factors, clinical features and serological response
Tóm tắt
Chronic kidney disease (CKD) and kidney transplantation in adults are well-recognized risk factors for coronavirus disease 2019 (COVID-19) associated morbidity and mortality. Data on the toll of the pandemic on children and young adults with kidney disease is scarce. The aim of this study was to assess the incidence and severity of COVID-19, as well as the serological response, in this population. Study population included all patients with CKD stage 3–5, glomerular disease treated with immunosuppression and kidney transplant recipients followed-up at a tertiary medical center, between 1.12.2020 and 15.2.2021. Data collected included PCR testing, symptoms, exposure, and socio-demographic data. Anti-SARS-CoV-2 antibodies were tested. A total of 197 children and 63 young adults were included, 57% were Jewish, 43% were Arab. PCR-confirmed COVID-19 incidence was 20.8%, 37% of cases were asymptomatic, three patients were hospitalized for observation, and the remainder had mild symptoms. Kidney function remained stable without treatment modification. Risk factors for infection included exposure at home (OR 15.4, 95% CI 6.9–34.2) and number of household members (OR 1.45, 95% CI 1.21–1.73). Anti-SARS-CoV-2 antibodies were detected in 61% of cases and were not associated with COVID-19 severity or immunosuppressive therapy. Three patients who did not develop antibodies had a mild recurrent infection. Unlike COVID-19 in adult patients with kidney disease, in our cohort of children and young adults, COVID-19 incidence was similar to the general population and all cases were mild. It may be unnecessary to impose severe restrictions on this patient population during the pandemic.
Tài liệu tham khảo
Williamson EJ, Walker AJ, Bhaskaran K et al (2020) Factors associated with COVID-19-related death using OpenSAFELY. Nature 584:430–436. https://doi.org/10.1038/s41586-020-2521-4
Ravanan R, Callaghan CJ, Mumford L et al (2020) SARS-CoV-2 infection and early mortality of waitlisted and solid organ transplant recipients in England: a national cohort study. Am J Transplant 20:3008–3018. https://doi.org/10.1111/ajt.16247
Valeri AM, Robbins-Juarez SY, Stevens JS et al (2020) Presentation and outcomes of patients with ESKD and COVID-19. J Am Soc Nephrol 31:1409–1415. https://doi.org/10.1681/ASN.2020040470
Akalin E, Azzi Y, Bartash R et al (2020) Covid-19 and kidney transplantation. N Engl J Med 382:2475–2477. https://doi.org/10.1056/NEJMc2011117
Cravedi P, Mothi SS, Azzi Y et al (2020) COVID-19 and kidney transplantation: results from the TANGO International Transplant Consortium. Am J Transplant 20:3140–3148. https://doi.org/10.1111/ajt.16185
Elias M, Pievani D, Randoux C et al (2020) COVID-19 infection in kidney transplant recipients: disease incidence and clinical outcomes. J Am Soc Nephrol 31:2413–2423. https://doi.org/10.1681/ASN.2020050639
Jager KJ, Kramer A, Chesnaye NC et al (2020) Results from the ERA-EDTA Registry indicate a high mortality due to COVID-19 in dialysis patients and kidney transplant recipients across Europe. Kidney Int 98:1540–1548. https://doi.org/10.1016/j.kint.2020.09.006
Peaper DR, Murdzek C, Oliveira CR et al (2021) Severe acute respiratory syndrome coronavirus 2 testing in children in a large regional US health system during the coronavirus disease 2019 pandemic. Pediatr Infect Dis J 40:175–181. https://doi.org/10.1097/INF.0000000000003024
Derespina KR, Kaushik S, Plichta A et al (2020) Clinical manifestations and outcomes of critically ill children and adolescents with coronavirus disease 2019 in New York City. J Pediatr. https://doi.org/10.1016/j.jpeds.2020.07.039
Gandhi RT, Lynch JB, Del Rio C (2020) Mild or moderate Covid-19. N Engl J Med 383:1757–1766. https://doi.org/10.1056/NEJMcp2009249
(2020) Population, by population group, religion, age and sex, district and sub-district. Central Bureau of Statistics. https://www.cbs.gov.il/he/publications/doclib/2020/2.shnatonpopulation/st02_19x.pdf. Accessed 15 Sept 2020
(2021) Israel Government Databases: young population data. Israeli Ministry of Health. https://data.gov.il/dataset/covid-19/resource/767ffb4e-a473-490d-be80-faac0d83cae7. Accessed 24 Feb 2021
Mastrangelo A, Morello W, Vidal E et al (2021) Impact of COVID-19 pandemic in children with CKD or immunosuppression. Clin J Am Soc Nephrol 16:449–451. https://doi.org/10.2215/CJN.13120820
Varnell C Jr, Harshman LA, Smith L et al (2021) COVID-19 in pediatric kidney transplantation: the improving renal outcomes collaborative. Am J Transplant 21:2740–2748. https://doi.org/10.1111/ajt.16501
Marlais M, Wlodkowski T, Al-Akash S et al (2020) COVID-19 in children treated with immunosuppressive medication for kidney diseases. Arch Dis Child. https://doi.org/10.1136/archdischild-2020-320616
Soriano-Arandes A, Gatell A, Serrano P et al (2021) Household SARS-CoV-2 transmission and children: a network prospective study. Clin Infect Dis. https://doi.org/10.1093/cid/ciab228 (Epub ahead of print)
Siebach MK, Piedimonte G, Ley SH (2021) COVID-19 in childhood: transmission, clinical presentation, complications and risk factors. Pediatr Pulmonol 56:1342–1356. https://doi.org/10.1002/ppul.25344
Hu S, Wang W, Wang Y et al (2021) Infectivity, susceptibility, and risk factors associated with SARS-CoV-2 transmission under intensive contact tracing in Hunan, China. Nat Commun 12:1533. https://doi.org/10.1038/s41467-021-21710-6
Goss MB, Galvan NTN, Ruan W et al (2021) The pediatric solid organ transplant experience with COVID-19: an initial multi-center, multi-organ case series. Pediatr Transplant 25:e13868. https://doi.org/10.1111/petr.13868
Abu-Raddad LJ, Chemaitelly H, Malek JA et al (2020) Assessment of the risk of SARS-CoV-2 reinfection in an intense re-exposure setting. Clin Infect Dis. https://doi.org/10.1093/cid/ciaa1846
Munitz A, Yechezkel M, Dickstein Y et al (2021) The rise of SARS-CoV-2 variant B.1.1.7 in Israel intensifies the role of surveillance and vaccination in elderly. medRxiv
Dobaño C, Ramirez A, Alonso S et al (2021) Persistence and baseline determinants of seropositivity in health care workers up to nine months after COVID-19, PREPRINT (Version 1). In: Research Square
National S-C-SaEG (2020) Performance characteristics of five immunoassays for SARS-CoV-2: a head-to-head benchmark comparison. Lancet Infect Dis 20:1390–1400. https://doi.org/10.1016/S1473-3099(20)30634-4
Liu C, Yu X, Gao C et al (2021) Characterization of antibody responses to SARS-CoV-2 in convalescent COVID-19 patients. J Med Virol 93:2227–2233. https://doi.org/10.1002/jmv.26646
Long QX, Liu BZ, Deng HJ et al (2020) Antibody responses to SARS-CoV-2 in patients with COVID-19. Nat Med 26:845–848. https://doi.org/10.1038/s41591-020-0897-1
Wajnberg A, Mansour M, Leven E et al (2020) Humoral response and PCR positivity in patients with COVID-19 in the New York City region, USA: an observational study. Lancet Microbe 1:e283–e289. https://doi.org/10.1016/S2666-5247(20)30120-8
Prendecki M, Clarke C, Gleeson S et al (2020) Detection of SARS-CoV-2 antibodies in kidney transplant recipients. J Am Soc Nephrol 31:2753–2756. https://doi.org/10.1681/ASN.2020081152
Petersen LR, Sami S, Vuong N et al (2020) Lack of antibodies to SARS-CoV-2 in a large cohort of previously infected persons. Clin Infect Dis 4:ciaa1685. https://doi.org/10.1093/cid/ciaa1685
Morello W, Mastrangelo A, Guzzo I et al (2021) Prevalence of SARS-CoV-2-IgG antibodies in children with CKD or immunosuppression. Clin J Am Soc Nephrol 16:1097–1099. https://doi.org/10.2215/CJN.00330121
Descamps-Latscha B (1993) The immune system in end-stage renal disease. Curr Opin Nephrol Hypertens 2:883–891. https://doi.org/10.1097/00041552-199311000-00005
Weisberg SP, Connors TJ, Zhu Y et al (2021) Distinct antibody responses to SARS-CoV-2 in children and adults across the COVID-19 clinical spectrum. Nat Immunol 22:25–31. https://doi.org/10.1038/s41590-020-00826-9
Hartzell S, Bin S, Benedetti C et al (2020) Evidence of potent humoral immune activity in COVID-19-infected kidney transplant recipients. Am J Transplant 20:3149–3161. https://doi.org/10.1111/ajt.16261
Benotmane I, Gautier-Vargas G, Wendling MJ et al (2020) In-depth virological assessment of kidney transplant recipients with COVID-19. Am J Transplant 20:3162–3172. https://doi.org/10.1111/ajt.16251
Phipps WS, Sorelle JA, Li QZ et al (2020) SARS-CoV-2 antibody responses do not predict COVID-19 disease severity. Am J Clin Pathol 154:459–465. https://doi.org/10.1093/ajcp/aqaa123
Benotmane I, Gautier-Vargas G, Velay A et al (2020) Persistence of SARS-CoV-2 antibodies in kidney transplant recipients. Am J Transplant (Epub ahead of print)